Causal mapping of human brain function

SH Siddiqi, KP Kording, J Parvizi, MD Fox - Nature reviews …, 2022 - nature.com
Mapping human brain function is a long-standing goal of neuroscience that promises to
inform the development of new treatments for brain disorders. Early maps of human brain …

Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential treatments

P Maiti, J Manna, GL Dunbar - Translational neurodegeneration, 2017 - Springer
Gradual degeneration and loss of dopaminergic neurons in the substantia nigra, pars
compacta and subsequent reduction of dopamine levels in striatum are associated with …

Co-evolution of machine learning and digital technologies to improve monitoring of Parkinson's disease motor symptoms

AS Chandrabhatla, IJ Pomeraniec… - NPJ digital …, 2022 - nature.com
Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor
impairments such as tremor, bradykinesia, dyskinesia, and gait abnormalities. Current …

Nanotherapeutics for nose-to-brain drug delivery: an approach to bypass the blood brain barrier

D Lee, T Minko - Pharmaceutics, 2021 - mdpi.com
Treatment of neurodegenerative diseases or other central nervous system (CNS) disorders
has always been a significant challenge. The nature of the blood-brain barrier (BBB) limits …

[HTML][HTML] Neurosurgery and artificial intelligence

M Mofatteh - AIMS neuroscience, 2021 - ncbi.nlm.nih.gov
Neurosurgeons receive extensive and lengthy training to equip themselves with various
technical skills, and neurosurgery require a great deal of pre-, intra-and postoperative …

Cognition and depression following deep brain stimulation of the subthalamic nucleus and globus pallidus pars internus in Parkinson's disease: a meta-analysis

HL Combs, BS Folley, DTR Berry, SC Segerstrom… - Neuropsychology …, 2015 - Springer
Parkinson's disease (PD) is a common, degenerative disorder of the central nervous system.
Individuals experience predominantly extrapyramidal symptoms including resting tremor …

Small non-coding RNAs: new class of biomarkers and potential therapeutic targets in neurodegenerative disease

CN Watson, A Belli, V Di Pietro - Frontiers in genetics, 2019 - frontiersin.org
Neurodegenerative diseases (NDs) are becoming increasingly prevalent in the world, with
an aging population. In the last few decades, due to the devastating nature of these …

Mesenchymal stem cells-derived exosomes: a new possible therapeutic strategy for Parkinson's disease?

H Vilaça-Faria, AJ Salgado, FG Teixeira - Cells, 2019 - mdpi.com
Parkinson's disease (PD) is the second most prevalent neurodegenerative disorder
worldwide. Clinically, it is characterized by severe motor complications caused by a …

Deep brain stimulation for the management of refractory neurological disorders: a comprehensive review

JP Rissardo, NM Vora, I Tariq, A Mujtaba, ALF Caprara - Medicina, 2023 - mdpi.com
In recent decades, deep brain stimulation (DBS) has been extensively studied due to its
reversibility and significantly fewer side effects. DBS is mainly a symptomatic therapy, but the …

Deformable MR-CT image registration using an unsupervised, dual-channel network for neurosurgical guidance

R Han, CK Jones, J Lee, P Wu, P Vagdargi… - Medical image …, 2022 - Elsevier
Purpose The accuracy of minimally invasive, intracranial neurosurgery can be challenged
by deformation of brain tissue–eg, up to 10 mm due to egress of cerebrospinal fluid during …